NCT07707297 BIOANCIENT: Cohort of Centenarians in Navarra (1926-1927)
| NCT ID | NCT07707297 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion Miguel Servet |
| Condition | Aging |
| Study Type | OBSERVATIONAL |
| Enrollment | 333 participants |
| Start Date | 2026-02-04 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 333 participants in total. It began in 2026-02-04 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Demographic aging is a growing global challenge, driven by increasing life expectancy and declining birth rates, with projections indicating that more than 30% of the European population will be over 65 years old by 2100. Centenarians represent a unique biological model of extreme longevity, often exhibiting delayed onset of age-related diseases and preserved functional capacity. This study aims to establish an intergenerational cohort of centenarians in Navarra (Spain) to investigate the biological, clinical, environmental, and lifestyle factors associated with extreme longevity. By integrating multidimensional data-including clinical assessments, functional and cognitive measures, and biological markers-this study seeks to improve understanding of aging mechanisms and identify potential determinants of healthy aging.
Eligibility Criteria
Inclusion Criteria: * Individuals aged ≥100 years * Residents of Navarre, Spain Exclusion Criteria: * Clinical decompensation within the last month, including hemodynamic instability, acute illness, or hospitalization; * End-of-life condition, defined as a clinical state of irreversible deterioration with a life expectancy of days to weeks, as determined by a physician.
Contact & Investigator
Nicolas Martínez Velilla, MD and PhD
PRINCIPAL INVESTIGATOR
Navarrabiomed, Hospital Universitario de Navarra, IdisNa, Universidad Pública de Navarra
Frequently Asked Questions
Who can join the NCT07707297 clinical trial?
This trial is open to participants of all sexes, aged 100 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07707297 currently recruiting?
Yes, NCT07707297 is actively recruiting participants. Contact the research team at nicolas.martinez.velilla@navarra.es for enrollment information.
Where is the NCT07707297 trial being conducted?
This trial is being conducted at Pamplona, Spain.
Who is sponsoring the NCT07707297 clinical trial?
NCT07707297 is sponsored by Fundacion Miguel Servet. The principal investigator is Nicolas Martínez Velilla, MD and PhD at Navarrabiomed, Hospital Universitario de Navarra, IdisNa, Universidad Pública de Navarra. The trial plans to enroll 333 participants.